AMR through
Genomics

The TARGetAMR Network is proudly supportingWorld Antimicrobial Awareness Week (WAAW)
18th - 24th November 2025


Transdisciplinary Antimicrobial Resistance Genomics Network (TARGetAMR)
Join us on our mission to build a national research network to enhance the use of AMR (antimicrobial resistance) genomics by fostering collaboration across various disciplines with the ultimate aim to improve surveillance and diagnostics, and inform prevention and treatment strategies for drug-resistant infections.
Reducing AMR through Genomics
Modern genomic methodologies are revolutionising our understanding of microbial diversity, but its benefits have not yet been fully realised in healthcare and veterinary medicine. TARGetAMR aims to create a multidisciplinary community of researchers and stakeholders to move AMR genomics to the next level.


TARGetAMR Annual Conference 2026
Building the future of AMR Genomics
Thursday 14th May 2026 & Friday 15th May 2026
The Studio, 7 Cannon St, Birmingham B2 5EP.
Join us in Birmingham for the TARGetAMR Annual Conference 2026, a two-day, in-person event dedicated to shaping the future of antimicrobial resistance (AMR) genomics.
Registration now open!

Quarterly Insight Sharing Webinar
Joint TARGetAMR & CLIMAR Networks
Building Resilience: AMR Genomics and Climate Change Perspectives
Monday 26th January 2026, 1 – 4pm – Online (Via TEAMS)
Guest Speakers:
-
-
-
- Dr Paul Kadetz, Senior Lecturer and coordinator of Doctoral Studies in the Institute for Global Health and Development at Queen Margaret University.
- Dr Dan Padfield, NERC Independent Research fellow within the Centre for Ecology and Conservation, University of Exeter.
- Dr Craig Baker-Austin, Head of Domain – Environmental Microbiology, CEFAS.
- Professor David Aanensen, Director of the Centre for Genomic Pathogen Surveillance.
An interactive and engaging event exploring fungal AMR and genomics from foundational knowledge to cutting-edge research.
-
-
Meet The TARGet AMR Leadership Team

PROFESSOR WILLEM VAN SCHAIK
Willem van Schaik is a Professor of Microbiology and Infection and the Director of the Institute of Microbiology and Infection (IMI) at the University of Birmingham.
He has published over 80 papers on molecular microbiology, the human microbiome, and antibiotic resistance. His research focuses on how commensal bacteria evolve into multi-drug resistant opportunistic pathogens and the analysis of the reservoir of antibiotic resistance genes (the "resistome") in complex microbial ecosystems.
Willem has received major research grants from the BBSRC, European Commission, JPIAMR, and The Royal Society. His work is highly regarded in the field of antimicrobial resistance, contributing to important advances in understanding bacterial adaptation and resistance.

PROFESSOR KATE BAKER
Professor Kate Baker is a Professor of Genomic Epidemiology at the University of Cambridge. She studies how pathogen genome variation and evolutionary processes impact their epidemiology and control.
Her research focuses particularly on the dynamics of the accessory genome in bacterial populations, including antimicrobial resistance. Using a combination of microbial genomics, epidemiological approaches, and molecular microbiology, she and her team investigate disease processes at both patient and public health levels, working in collaboration with clinicians, public health practitioners, in vivo experimentalists, and mathematical modellers.
Their work spans both high-income and lower- to middle-income nation settings. Additionally, Professor Baker has a strong interest in knowledge exchange and policy, and has held various external secondments with GO-Science, SEDRIC, and UKHSA.

DR STEPHANIE JOHNSON
Stephanie Johnson is a Senior Researcher in Ethics at the Ethox Centre and the Wellcome Centre for Ethics and Humanities at the University of Oxford.
Her research focuses on the ethics of genomics and infectious disease, with a particular interest in infectious disease transmission and control and relational bioethics in public health. She co-leads a module for Oxford Population Health’s MSc in Clinical Trials and supervises DPhil and undergraduate research. A member of the GLIDE Collaborative, Stephanie held a Wellcome Trust Fellowship (2020-2023) on the ethics of tracking microbes.
She collaborates with Oxford’s Big Data Institute and advises policy makers at institutions like Genomics England and the Africa CDC. Her work blends empirical research with theoretical analysis.

PROFESSOR PAUL FLOWERS
Professor Paul Flowers is Associate Dean of Research at the School of Health and Life Sciences and holds a personal Chair as Professor of Sexual Health Psychology.
He is an Academician of the Academy of Social Sciences and a registered Health Psychologist. His research focuses on sexual health, with a particular emphasis on improving and maintaining sexual health among marginalized communities, including gay men. He has contributed to policy development, including NHS QIS standards for HIV care and Scotland's HIV action plan.
Professor Flowers has a strong interest in methodological innovation, particularly in mixed methods and Interpretative Phenomenological Analysis (IPA). He is also a Trustee of the National AIDS Trust, combining academic research with applied public health initiatives.

DR NICOLE WHEELER
Dr. Nicole Wheeler's work focuses on developing computational tools to detect DNA from emerging biological threats, establishing genomic pathogen surveillance in resource-limited settings, and conducting One Health surveillance of antimicrobial resistance.
She is also committed to the ethical development of AI for health applications. With a background in biochemistry and microbial genomics, Dr. Wheeler specialises in using machine learning to predict the effects of genetic variation on pathogen virulence. She has provided expertise for international programs, including an AI-driven One Health AMR surveillance system.
In addition, Dr. Wheeler is actively involved in public outreach and the creation of governance frameworks to ensure the safe and responsible advancement of health technologies.

MR KEVIN DUNN
Kevin is a Senior Research Programme Manager at the University of Birmingham, leading the Multi-Sector Networks pillar that supports a diverse portfolio of health-related research. He manages the HDR UK Midlands regional network, which enhances health data science across the Midlands by uniting academic, clinical, and other stakeholders.
Additionally, he provides strategic and operational support to the national TARGetAMR research network, which focuses on combating antimicrobial resistance through genomics and fostering interdisciplinary collaboration.
Beginning his NHS career as a Youth Trainee in 1998, Kevin has expertise in Health Informatics, Oncology, R&D and Innovation Management. He has worked at local, regional, and national levels and currently teaches on the Health Data Fundamentals module, part of the MSc Health Data Science programme at the University of Birmingham.


Latest News
November 21, 2025
TARGetAMR Marks World Antimicrobial Awareness Week 2025
February 19, 2025
Genomics Meets AMR: Insights from the First TARGetAMR Webinar
December 17, 2024
Uniting Minds to Fight AMR: Highlights from EADA 2024
November 19, 2024
TARGetAMR Supports World Antimicrobial Awareness Week 2024
November 5, 2024
TARGetAMR Network Reaches 100 Members
October 30, 2024
TARGetAMR Network Now Live on Social Media!




Join us for the next TARGetAMR Monthly Webinar Series:
Estimating the fitness cost and benefit of antimicrobial resistance from pathogen genomic data
Professor Xavier Didelot, Professor of Statistical Epidemiology and Genomics, University of Warwick
ECR Presentation: Linking socioeconomic deprivation to antimicrobial resistance exposure risks in the aquatic environment
Jack Barber, PhD student, University of Aberdeen.
Wednesday 18 March 2026 at 12pm
TARGetAMR is building a diverse national research network across the UK to facilitate cross-disciplinary collaboration, and drive forward the fight against AMR through collaboration, strategic planning and public engagement.
Discover a new era of antimicrobial Research
Discover the different objectives of the TARGetAMR Network and explore how our community will make a difference to use genomics to reduce the risks posed by antimicrobial resistance. Join us on our journey as we explore new solutions.
- BUILDING THE NETWORK:The project starts by recruiting researchers and stakeholders from various disciplines. This involves setting up a website, engaging through social media, and using conferences to attract members. The goal is to expand the network and involve diverse experts in AMR genomics
- CREATE SYNERGIESIn the first year, TARGetAMR will gather input from its members to identify key challenges and opportunities in AMR genomics. This will include surveys and monthly webinars where members share insights. There will be in-person meetings in Years 2 and 4 to discuss progress and develop research strategies.
- IMPLEMENT AND DELIVERStarting in Year 2, TARGetAMR will offer funding for projects that encourage crossdisciplinary research. This support aims to address specific research questions and foster collaborative work. Year 4 will feature another major meeting to showcase progress, share findings, and plan for future research.
- OUTREACH AND ENGAGEMENTTARGetAMR will publish its findings and engage with both the public and stakeholders through various channels, including media articles and public events. There will also be a Summer School to train students in transdisciplinary research.
- FUTURE PLANNINGThe project will collect successful case studies and feedback to refine its approach and secure ongoing funding beyond the initial four years.















